Company Logo

3.68 USD

0.16 (4.55%)

Last updated Nov 20, 2:30 PM

Yesterday High

$3.59

Yesterday Low

$3.38

52w High

$20.25

52w Low

$2.96

Market Cap.

$183.2M

52w Change

-53.13%

This is a preview of the full version of Prosperse

Trending News

Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

Hagens Berman is investigating Cardlytics, Inc. (CDLX) over allegations that the company may have misled investors about the prospects of its growth initiatives. The investigation follows Cardlytics' Q2 2024 financial results, which fell short of previous projections, leading to a 57% drop in the co...

N/A

Sep 16, 2024

Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential securities law violations by Arhaus, Cardlytics, and CVRx. The investigations focus on issues related to financial reporting, CEO departures, and reimbursement changes.

N/A

Aug 27, 2024

Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

Hagens Berman, a shareholder rights firm, is investigating Cardlytics, Inc. (NASDAQ: CDLX) over allegations that the company may have misled investors about the prospects of its growth initiatives. The investigation follows Cardlytics' Q2 2024 financial results, which fell short of previous projecti...

N/A

Aug 19, 2024

Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman

Hagens Berman, a shareholder rights firm, is investigating Cardlytics, Inc. (NASDAQ: CDLX) over allegations that the company may have misled investors about the prospects of its growth initiatives. The investigation follows Cardlytics' Q2 2024 financial results, which fell short of previous projecti...

N/A

Aug 13, 2024

Login to view more news

Dive into the world of investing with Prosperse

Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.

Read more news from Prosperse